← Evidence map

ArticleJBMR plus2025

Impact of romosozumab treatment for 24 months after switching from denosumab: three case reports.

Seong Hee Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40708567